News of Note—Cancer diagnostics startup Celcuity files for $15M IPO

News of note

> Cancer diagnostics startup Celcuity filed to raise up to $15 million in an IPO. The Minneapolis-based company is working on its CELx platform, which analyzes live tissue to pinpoint the specific abnormal activity that drives a patient’s cancer. Release

> The FDA cleared Titan Pharmaceuticals’ phase 1/2 clinical study of its ropinirole-delivering implant for the treatment of Parkinson’s disease. Release

Suggested Articles

The FDA approved the first spinal tether to correct the most common form of scoliosis—a ropelike implant that pulls the vertebrae into shape.

Agilent launched a new analyzer for research that observes cell behavior in real time while also collecting biosensor information.

Five years after Congress passed a law to reduce unnecessary MRIs and CT scans, federal officials have yet to implement it.